Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Cash from Investing Activities (2020 - 2026)

Barinthus Biotherapeutics (BRNS) has disclosed Cash from Investing Activities for 7 consecutive years, with $55000.0 as the latest value for Q1 2026.

  • For Q1 2026, Cash from Investing Activities rose 1200.0% year-over-year to $55000.0; the TTM value through Mar 2026 reached $476000.0, up 180.81%, while the annual FY2025 figure was $416000.0, 146.64% up from the prior year.
  • Cash from Investing Activities hit $55000.0 in Q1 2026 for Barinthus Biotherapeutics, up from $2000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $451000.0 in Q3 2025 and bottomed at -$3.0 million in Q2 2023.
  • Average Cash from Investing Activities over 5 years is -$681411.8, with a median of -$192000.0 recorded in 2024.
  • Year-over-year, Cash from Investing Activities crashed 1476.56% in 2022 and then skyrocketed 1200.0% in 2026.
  • Barinthus Biotherapeutics' Cash from Investing Activities stood at -$586000.0 in 2022, then soared by 126.11% to $153000.0 in 2023, then crashed by 281.7% to -$278000.0 in 2024, then surged by 100.72% to $2000.0 in 2025, then skyrocketed by 2650.0% to $55000.0 in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $55000.0, $2000.0, and $451000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.